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| INTRODUCTION
Posttransplantation diabetes mellitus (PTDM) is a frequent complication in patients treated with the immunosuppressive calcineurin inhibitor tacrolimus (Tac; FK506). Approximately 30%-40% of liver transplant recipients have sustained diabetes beyond 6 months after transplant. 1 The true prevalence of insulin resistance in patients after liver transplantation is unknown but presumed to be even greater. It is important to find biological markers that can predict the risk of PTDM;
this could also provide new ideas for individualized therapies. Recent studies have identified single nucleotide polymorphisms (SNPs) associated with PTDM risk among Tac-treated patients. 2 It has been suggested that genotyping diabetes-related polymorphisms could be a possible method of predicting a patient's risk for developing PTDM, and this information could be a valuable asset in the selection of appropriate immunosuppressive regimens. 2 Posttransplantation diabetes mellitus is characterized by a combination of insulin resistance and insulin hyposecretion in liver transplant recipients. It has been reported that there is a particularly high prevalence of insulin resistance associated with viral epidemic diseases. Although the mechanism by which virus infection promotes insulin resistance is not fully understood, viral eradication has been shown to improve insulin sensitivity. Chronic hepatitis C virus (HCV) infection has been reported to be associated with a high prevalence of insulin resistance, both in the pre-and posttransplant setting. In addition, sustained virological response (SVR) to antiviral treatment has been shown to improve insulin sensitivity. It was demonstrated that genetic IL28B polymorphisms coding for IFN-λ are strongly associated with SVR to pegIFN-α treatment for chronic HCV infection. Because IFN-λ, in analogy with IFN-α, may act on IFN-stimulated genes (ISGs) via suppressor of cytokine signaling (SOCS) and the JAK-STAT pathway, IL28B polymorphisms might also be associated with development of diabetes mellitus (DM) in HCV patients during long-term follow-up after liver transplantation. 4, 5 But in our previous study we did not find significant association between IL-28B SNPs and hepatitis B virus (HBV) natural clearance, this made us to consider whether IL-28B SNPs were associated with PTDM of HBV patients after liver transplantation (LT). 6 As is known, the prevalence of hepatitis virus infection varies greatly based on region disparity. In North America and Europe, the prevalence of HBV infection is rather low, but in East Asia, this number soars up; the prevalence of HCV is rather opposite. This difference can be truly originated from race disparity since the degree of genetic variations differs among individuals of different races. 7, 8 Therefore, we want to explore whether IL-28B SNPs are associated with insulin resistance and PTDM in Chinese Han people.
Genome-wide association studies have demonstrated SNPs of human leukocyte antigen (HLA) might be correlated with virus clearance after infection with HBV, especially polymorphisms on HLA-DP/ DQ loci. 9 Another study conducted in the Chinese Han population substantiated that polymorphisms of signal transducer and activator of transcription 4 (STAT4) might correlate with progression of hepatocellular carcinoma (HCC) after HBV infection. 10 Inflammatory factor IL-18 was reported to take part in the antivirus reaction, but whether these factors correlate with expression of SOCS and insulin resistance still remains elusive. Our studies focus on the association between SNPs of HLA-DP/DQ, STAT4, IL-28B, IL-18, and insulin resistance or PTDM. We are trying to clarify the importance of these host genetic factors on insulin resistance and to find some markers for PTDM.
| METHODS AND MATERIALS

| Subjects
The present study recruited Chinese Han people as subjects. All the subjects were recruited from West China Hospital of Sichuan This study was approved by the ethics committee of our hospital, and the methods were carried out in accordance with the approved guidelines. All patients signed an informed consent prior to inclusion in this study.
| Genomic DNA extraction
Blood samples (3 mL) were collected in ethylenediaminetetraacetic acid tubes, and genomic DNA was isolated from whole blood samples using the whole blood DNA kit (Biotake Corporation, Beijing, China). 
| Polymerase chain reaction
HLA-DP (rs3077, rs9277535), HLA-DQ (rs7453920), STAT4
(rs7574865) polymorphisms, IL-28B (rs12979860, rs8099917, and rs12980275), and IL-18 (rs1946518 and rs187238) were investigated in this study. Primers for the nine SNPs are shown in Table S1 . All the nine SNPs were genotyped using polymerase chain reaction high- 
| High-resolution melting curve analysis
The 
| Cytokines and chemokines detection
Plasma was collected for cytokines and chemokines detection. IL-1β, 
| Logistic regression and statistical analysis
The Hard-Weinberg Equilibrium (HWE) was determined using the A P value <.05 indicated the statistical significance.
Logistic regression models were used for calculating odds ratios (95% confidence interval) and corresponding P values for each clinical and laboratory characteristics using SPSS. All of the variables were included for single factor regression, and then the parameters that had significant predict value were included for multivariate regression. Age (continuous value) and sex (male = 0, female = 1) were adjusted by inclusion in logistic analysis as covariates.
All of the experimental protocols were approved by the ethics committee of West China Hospital of Sichuan University.
| RESULTS
The detailed clinical characteristics of the subjects were depicted in Table 1 . No difference existed in the proportion of male vs female in both the PTDM and non-PTDM groups. There were significant differences between PTDM and non-PTDM recipients in their triglyceride, cholesterol, urea nitrogen, glucose, and glycosylated hemoglobin A1C;
this may have resulted from abnormal glucose metabolism, which disrupts lipid metabolism and kidney function.
All the genotype distributions in both groups of the SNPs were in
Hardy-Weinberg equilibrium (P > .05). The association of IL-28B and HLA-DP/DQ genotypes with these glucose metabolic problems was not adequately powered to reach statistical significance and may require further study; however, PTDM was associated with STAT4 (rs7574865) polymorphisms and IL-18 (rs1946518) polymorphisms (Table 2 ). The most important observation in our current study is that STAT4 (rs7574865) T allele and IL-18 (rs1946518) A allele may increase the risk for insulin resistance and PTDM. When the liver transplantation recipients were divided into two groups according to genotypes of STAT4 (rs7574865), the expression concentration of IL-1β, IFN-γ, MCP, and MIP-1b were significantly different.
Recipients with STAT4 (rs7574865) T allele are associated with an increased concentration of IL-1β, IFN-γ, MCP, and MIP-1b (Table 3 and Figure 1 ).
Because the sample size of PTDM was very small (only around 50), so the regression results was not very credible. Our logistic regression results indicated that Tac concentration, gamma-glutamyl transferase, serum glucose, hemoglobin A1C, MCP, and STAT4 rs7574865 were associated with the risk of PTDM ( other similar factors such as HLA-DP/DQ, STAT4, and IL-18 were newly reported to be associated with virus infection and progress of diseases; however, there has been no study about the relationship between insulin resistance and these factors. 16, 17 Meanwhile, inflammation and activation of the immune system are emerging as key mechanisms associated with type 2 diabetes. Adipose tissue inflammation was recently identified as an early indicator of insulin resistance and type 2 diabetes and as a contributor to disease susceptibility and progression. 18 Strong evidence from mouse models of obesity suggest that adipose tissue infiltration with proinflammatory macrophages, T cells, and natural killer cells leads to cytokine and chemokine production and free fatty acid release, which can induce pancreatic β-cell dysfunction, insulin resistance, and atherosclerosis. 19 Therefore, the concentration change of cytokine and chemokine induced by inflammation may be associated with insulin resistance and PTDM, so our study is focused on two items: the relationship between genetic variants and PTDM, and whether cytokines and chemokines are regulated by IL-28B, HLA-DP/DQ, STAT4, and IL-18, which take part in the cellular immune system regulation and inflammation. We wanted to find some new target or marker associated with PTDM.
| DISCUSSIONS
It was reported that IL-28B polymorphisms are strongly asso- STAT4 is a transcription factor that regulates the immune re- 
| Limitation
The sample size of liver transplantation recipients is not very big, let alone the sample size of PTDM, thus the results may be less persuasive and it could give us prompt significance. As many Chinese hospitals have transplantation centers, our next step is to consolidate the recipients and data together and collect more data of liver transplant recipients. Postoperative complications influence survival of transplant recipients significantly, so it is important to find new ideas (even if the conclusion is weak) to predict PTDM and other complications. 
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